Deferiprone is an effective oral iron chelator widely used to reduce iron overload in patients who have conditions like thalassemia, sickle cell disease, or anemia, and receive frequent blood transfusions. It functions by combining with iron in the bloodstream to facilitate its safe removal from the body, thus preventing potentially damaging iron accumulation in critical organs. The compound, with the molecular formula C7H9NO2, exhibits both hydrophobic and hydrophilic properties, allowing it to be efficiently absorbed in the gastrointestinal tract and distributed throughout the body. Deferiprone also demonstrates the ability to cross the blood-brain barrier, thereby decreasing iron buildup in the brain.
Parent: Deferiprone
Parent: Deferiprone
The pharmaceutical formulation of Deferiprone can contain some impurities and related compounds. These are often a result of the manufacturing process, storage conditions, or degradation over time. Typical impurities might include small amounts of residual solvents, reagents, or derivatives of Deferiprone. Rigorous analytical methods like High Performance Liquid Chromatography (HPLC) are used to identify and quantify these impurities. The total amount of impurities in a Deferiprone formulation is tightly regulated and must comply with the internationally accepted guidelines to ensure the safety and efficacy of the product.
Deferiprone tablets are used to reduce and manage excess iron in the body, typically resulting from regular blood transfusions in patients with conditions like thalassemia or sickle cell disease. By chelating or binding to the iron, Deferiprone allows this excess to be removed safely from the body.
The amount of iron that Deferiprone can remove varies depending on the iron overload in the patient’s body, the dosage of Deferiprone, and the individual response to the medication. It’s important to have regular blood tests to monitor iron levels while taking Deferiprone.
Another name for Deferiprone is Ferriprox. This is the brand name under which Deferiprone is sold in many markets.
Deferiprone belongs to the Biopharmaceutics Classification System (BCS) Class 1. This classification implies that Deferiprone has high solubility and high permeability, which allows it to be effectively absorbed into the body when taken orally.
